How GLP-1s Are Reshaping Restaurant Menus

The Trend: Somewhere between the COVID pandemic and the rise of Ozempic, our eating habits have changed from three meals a day to lots of grazing. In response, more and more restaurants (including chains like Olive Garden and Subway) have started rolling out options for smaller portions that are designed for people who want a little treat without the full-sized commitment. The timing tracks with the popularity of GLP-1 medications, which dramatically curb appetite and have been taken by roughly 12% of Americans as of late 2025.

What People Are Saying: GLP-1s are the most-cited explanation, but they’re not the only reason. Younger consumers generally tend to eat smaller amounts spread throughout the day rather than one big sit-down meal, and more people are socializing in ways that don’t revolve around drinking, which has made snacking a bigger part of a night out. Efforts to save money are also playing a role.

What to Know: Food industry analysts say this reflects a longer-term shift in how people view dining out, with priorities moving away from maximizing portion size to maximizing social experience. And while the higher-protein trend that often accompanies these smaller portions is important for people taking GLP-1s, it isn’t automatically healthier — dietitians warn that overemphasizing protein can crowd out other nutrients your body needs.